I started at the lab from October of 2016. Until then, I got my degree of M.D. from Kyushu University, School of Medicine, Fukuoka, Japan in 2003. After 4 years of clinical trainings (Internal Medicine/ Clinical Hematology) at International Medical Center of Japan (IMCJ), Tokyo, I started my research at the University of Tokyo, Graduate School of Medicine, Tokyo, Japan, where I got Ph.D. degree in 2011. Before coming to US, I continued my Hematology works at Institute of Medical Science, the University of Tokyo. My clinical/ research areas have focused on HSCT for HIV-associated malignant lymphoma, TGF-b signaling in lymphoma cells, and mouse models of acute myeloid leukemia / myelodysplastic syndrome. Based on these experience, I am developing novel therapeutic strategies of AML, using inhibitors against novel therapeutic targets in AML.